Characteristics of obesity and its related disorders in china

Biomedical and Environmental Sciences

Volumn 23, Issue 1, 2010, Pages 4-11

  Jia, Wei Ping ^a   Wang, Chen ^a   Jiang, Shan ^a   Pan, Jie Min ^a  

^a SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

Author keywords

Cardiovascular disease; Metabolic syndrome; Obesity; Type 2 diabetes

Indexed keywords

EID: 77952126921     PISSN: 08953988     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-3988(10)60025-6     Document Type: Article

References (79)

1. Vague J, Vague P (1974). Obesity and atherosclerosis. Horm Metab Res Suppl 4, 64-168.
2. Reaven G M (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37(12), 1595-1607.
3. 3. Fox C S, Massaro J M, Hoffmann U, et al. (2007). Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 116(1), 39-48. (Pubitemid 47016245)
4. 4. Carr D B, Utzschneider K M, Hull L, et al. (2004). Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 53(8), 2087-2094. (Pubitemid 38970759)
5. Després J P, Lemieux I (2006). Abdominal obesity and metabolic syndrome. Nature 444(7121), 881-887.
6. Wu Y (2006). Overweight and obesity in China. BMJ 333(7564), 362-363.
7. Ogden C L, Carroll M D, Curtin L R et al. (2006). Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295(13), 1549-1555.
8. WHO Technical Report Series 894 (1999). Obesity: prevention and managing the global epidemic. Geneva: World Health Organization.
9. 9. Ford E S, Giles W H, Dietz W H (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287(3), 356-359. (Pubitemid 34251969)
10. 10.Wang H, Du S, Zhai F, Popkin B M (2007). Trends in the distribution of body mass index among Chinese adults, aged 20-45 years (1989-2000). Int J Obes (Lond) 31(2), 272-278. (Pubitemid 46183133)
11. 11.Wang Y, Mi J, Shan X Y, et al. (2007). Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 31(1), 177-188. (Pubitemid 46006032)
12. Chen C, Lu F (2004). The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci 17(Suppl), 1-36.
13. 13.Jia W, Xiang K, Chen L, et al. (2002). Epidemiological study on obesity and its comorbidities in urban Chinese older than 20 years of age in Shanghai, China. Obes Rev 3(3), 157-165. (Pubitemid 34815234)
14. Hou X, Jia W, Bao Y, et al. (2008). Risk factors for overweight and obesity, and changes in body mass index of Chinese adults in Shanghai. BMC Public Health 8, 389.
15. Tian H, Xie H, Song G, et al. (2009). Prevalence of overweight and obesity among 2.6 million rural Chinese adults. Prev Med 48(1), 59-63.
16. Ma G, Li Y, Wu Y, et al. (2005). The prevalence of body overweight and obesity and its changes among Chinese people during 1992 to 2002. Chin J Prev Med 39(5), 311-315.
17. 17.Chen L, Jia W, Lu J, et al. (2003). Prevalence of metabolic syndrome among Shanghai adults in China. Chin J Cardiol 31(12), 909-912. (Pubitemid 38271155)
18. Jia W, Xiang K, Chen L, et al. (2004). A comparison of the application of two working definitions of metabolic syndrome in Chinese population. Nail Med J China 84(7), 534-538.
19. Li Z Y, Xu G B, Xia T A (2006). Prevalence rate of metabolic syndrome and dyslipidemia in a large professional population in Beijing. Atherosclerosis 184(1), 188-192.
20. 20. Yang W, Reynolds K, Gu D, et al. (2007). A comparison of two proposed definitions for metabolic syndrome in the Chinese adult population. Am J Med Sci 334(3), 184-189. (Pubitemid 47414992)
21. 21.Feng Y, Hong X, Li Z, et al. (2006). Prevalence of metabolic syndrome and its relation to body composition in a Chinese rural population. Obesity (Silver Spring) 14(11), 2089-2098. (Pubitemid 46127365)
22. He Y, Jiang B, Wang J, et al. (2006). Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population. J Am Coll Cardiol 47(8), 1588-1594.
23. Lu W, Liu M, Li R, et al. (2006). Epidemiological feature of metabolic syndrome in Shanghai residents aged 15-74 years. Chin J Prev Med 40(4), 262-268.
24. Jia W, Pang C, Chen L, et al. (2007). Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in Chinese adult population: The Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 50, 286-292.
25. 25.Wu Z, Yao C, Zhao D, et al. (2001). Sino-MONICA project: a collaborative study on trends and determinants in cardiovascular diseases in China, Part i: morbidity and mortality monitoring. Circulation 103(3), 462-468. (Pubitemid 32105989)
26. Liu L (2007). Cardiovascular diseases in China. Biochem Cell Biol 85(2), 157-163.
27. Forouhi N G, Sattar N (2006). CVD risk factors and ethnicity-a homogeneous relationship? Atheroscler Suppl 7(1), 11-19.
28. WHO Expert Consultation (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403), 157-163.
29. Low S, Chin M C, Ma S, et al. (2009). Rationale for redefining obesity in Asians. Ann Acad Med Singapore 38(1), 66-69.
30. Zhou B F, Cooperative Meta-Analysis Group of the Working Group on Obesity in China (2002). Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15(1), 83-96.
31. 31. Wildman R P, Gu D, Reynolds K, et al. (2004). Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr 80(5), 1129-1136. (Pubitemid 41350671)
32. Zhou B F (2002). Effect of Body Mass Index on All-cause Mortality and Incidence of Cardiovascular Diseases-Report for Meta-Analysis of Prospective Studies on Optimal Cut-off Points of Body Mass Index in Chinese Adults. Biomed Environ Sci 15(3), 245-252.
33. Bao Y, Lu J, Wang C, et al. (2008). Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 201(2), 378-384.
34. Ye Y, Bao Y, Hou X, et al. (2009). Identification of waist circumference cut-offs for abdominal obesity in the Chinese population: a 7.8-year follow-up study in the Shanghai urban area.Int J Obestiy Doi:10.1038/ijo.2009.134.
35. 35.Deurenberg-Yap M, Yian T B, Kai C S, et al. (1999). Manifestation of cardiovascular risk factors at low levels of body mass index and waist-to-hip ratio in Singaporean Chinese subjects. Asia Pacific J Clin Nutr 8, 177-183. (Pubitemid 129269149)
36. 36.Hsieh S D, Yoshinaga H, Muto T, et al. (2000). Health risks among Japanese men with moderate body mass index. Int J Obes Relat Metab Disord 24(3), 358-362. (Pubitemid 30137728)
37. Wang J, Russell-Aulet M, Mazariegos M, et al. (1992). Body fat by dual photon absorptiometry (DPA): comparisons with traditional methods in Asians, Blacks and Caucasians. Am J Hum Biol 4, 501-510.
38. Xiang K, Jia W, Lu J, et al. (2004). Obesity in type 2 diabetes , its feature and specificity. Natl Med J China 84(21), 1768-1772.
39. Alberti K G, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group (2005). The metabolic syndrome-a new worldwide definition. Lancet 366(9491), 1059-1062.
40. Examination Committee of Criteria for 'Obesity Disease' in Japan; Japan Society for the Study of Obesity (2002). New criteria for 'obesity disease' in Japan. Circ J 66(11), 987-992.
41. Kim J A, Choi C J, Yum K S (2006). Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population. J Korean Med Sci 21(6), 1048-1053.
42. Jia W, Lu J, Xiang K, et al. (2003). Prediction of abdominal visceral obesity from body mass index, waist circumference and waist-hip ratio in Chinese adults: receiver operating characteristic curve analysis. Biomed Environ Sci 16(3), 206-211.
43. 43.Oka R, Kobayashi J, Yagi K, et al. (2008). Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 79(3), 474-481. (Pubitemid 351273461)
44. Han J H, Park H S, Kim S M, et al. (2008). Visceral adipose tissue as a predictor for metabolic risk factors in the Korean population. Diabet Med 25(1), 106-110.
45. Joint Committee for Developing Chinese guidelines on Prevention and Treatment of Dyslipidemia in Adults (2007). Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chin J Cardiol 35(5), 390-419.
46. Wang C, Hou X, Bao Y, et al. (2008). The metabolic syndrome increased risk of cardiovascular events in Chinese-A community based study. Int J Cardiol Doi:10.1016/j.ijcard.2008.10.012.
47. Mao X, Kikani C K, Riojas R A, et al. (2006). APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat Cell Biol 8(5), 516-523.
48. 2+/calmodulin-dependent protein kinase kinase-dependent pathways. J Biol Chem 284(33), 22426-22435.
49. 49.Wang J, Li H, Franco O H, et al. (2008). Adiponectin and metabolic syndrome in middle-aged and elderly Chinese. Obesity (Silver Spring) 16(1), 172-178. (Pubitemid 351271968)
50. Zhuo Q, Wang Z, Fu P, et al. (2009). Comparison of adiponectin, leptin and leptin to adiponectin ratio as diagnostic marker for metabolic syndrome in older adults of Chinese major cities. Diabetes Res Clin Pract 84(1), 27-33.
51. 51.Scherer P E (2006). Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55(6), 1537-1545. (Pubitemid 44324105)
52. 52.Jia W, Wu H, Bao Y, et al. (2007). Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 92(8), 3224-3229. (Pubitemid 47236396)
53. 53.Han T S, Sattar N, Williams K, et al. (2002). Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 25(11), 2016-2021. (Pubitemid 41071061)
54. 54.Laaksonen D E, Niskanen L, Nyyssönen K, et al. (2004). C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47(8), 1403-1410. (Pubitemid 38579762)
55. 55.Lao X Q, Thomas G N, Jiang C Q, et al. (2007). C-Reactive protein and the metabolic syndrome in older Chinese: Guangzhou Biobank Cohort Study. Atherosclerosis 194(2), 483-489. (Pubitemid 47513082)
56. Wen J, Liang Y, Wang F, et al. (2009). Association of C-reactive protein and metabolic syndrome in a rural Chinese population. Clin Biochem 42(10-11), 976-983.
57. 57.Ye X, Yu Z, Li H, et al. (2007). Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 49(17), 1798-1805. (Pubitemid 46629126)
58. 58.Bao Y, Jia W, Chen L, et al. (2006). Association between C-reactive protein level and metabolic syndrome and components. Natl Med J China 86(30), 2105-2109. (Pubitemid 44489486)
59. Zuliani G, Volpato S, Galvani M, et al. (2009). Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the In Chianti study. Atherosclerosis 203(2), 626-632.
60. Visser M, Bouter L M, McQuillan G M, et al. (1999). Elevated C-reactive protein levels in overweight and obese adults. JAMA 282(22), 2131-2135.
61. 61.Schrager MA, Metter EJ, Simonsick E, et al. (2007). Sarcopenic obesity and inflammation in the InCHIANTI study. J Appl Physiol 102(3), 919-925. (Pubitemid 46377013)
62. Bastard J P, Maachi M, Lagathu C, et al. (2006). Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 17(1), 4-12.
63. Ridker P M, Buring J E, Cook N R, Rifai N (2003). C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107(3), 391-397.
64. Rutter M K, Meigs J B, Sullivan L M, et al. (2004). C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110(4), 380-385.
65. Ridker P M, Wilson P W, Grundy S M (2004). Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109(23), 2818-2825.
66. Jiang S, Bao Y, Hou X, et al. (2009). Serum C-reactive protein and risk of cardiovascular events in middle-aged and older chinese population. Am J Cardiol 103(12), 1727-1731.
67. 67.Albert M A, Glynn R J, Buring J, Ridker P M (2004). C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 93(10), 1238-1242. (Pubitemid 38595677)
68. Gami A S, Witt B J, Howard D E, et al. (2007). Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 49(4), 403-414.
69. Ford E S (2005). Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 28(7), 1769-1778.
70. 70.Galassi A, Reynolds K, He J (2006). Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med 119(10), 812-819. (Pubitemid 44415613)
71. Zhang W W, Liu C Y, Wang Y J, et al. (2009). Metabolic syndrome increases the risk of stroke: a 5-year follow-up study in a Chinese population. J Neurol 256(9), 1493-1499.
72. 72.Wilson P W, D'Agostino R B, Parise H, et al. (2005). Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 112(20), 3066-3072. (Pubitemid 43113437)
73. 73.Zhao D, Grundy S M, Wang W, et al. (2007). Ten-year cardiovascular disease risk of metabolic syndrome without central obesity in middle-aged Chinese. Am J Cardiol 100(5), 835-839. (Pubitemid 47268276)
74. Ford E S, Li C, Sattar N (2008). Metabolic syndrome and incident diabetes: current state of the evidence. Diabetes Care 31(9), 1898-1904.
75. 75.Cheung B M, Wat N M, Man Y B, et al. (2007). Development of diabetes in Chinese with the metabolic syndrome: a 6-year prospective study. Diabetes Care 30(6), 1430-1436. (Pubitemid 46871150)
76. 76.Kahn R, Buse J, Ferrannini E, et al. (2005). The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 28(9), 2289-2304. (Pubitemid 41242486)
77. 77.Wang J J, Li H B, Kinnunen L, et al. (2007). How well does the metabolic syndrome defined by five definitions predict incident diabetes and incident coronary heart disease in a Chinese population? Atherosclerosis 192(1), 161-168. (Pubitemid 46602293)
78. 78.Wang J J, Qiao Q, Miettinen M E, et al. (2004). The metabolic syndrome defined by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose. Diabetes Care 27(10), 2429-2437. (Pubitemid 39281397)
79. 79.Shai I, Jiang R, Manson J E, et al. (2006). Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care 29(7), 1585-1590. (Pubitemid 44127585)